|Bid||150.92 x 1300|
|Ask||151.09 x 900|
|Day's range||150.22 - 151.95|
|52-week range||122.18 - 165.35|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||26.16|
|Earnings date||19 Jan 2023|
|Forward dividend & yield||3.65 (2.45%)|
|Ex-dividend date||20 Oct 2022|
|1y target est||148.60|
CINCINNATI, December 09, 2022--Vicks® PURE Zzzs Kidz is aiding the work of over 300 Sleep in Heavenly Peace (SHP) chapters across the US to help communities and people most in need get better sleep. As a sponsor of Bunks Across America in September, where SHP chapters across the country built bunk beds together, Vicks® PURE Zzzs Kidz will help enable SHP to deliver over 2,000 beds at the 2nd Annual Deliveries Across America event on December 10th.
Procter & Gamble (NYSE: PG) isn't the first stock you'd think of when naming risky investments. The consumer staples giant has been consistently profitable for decades, and its massive global selling footprint makes it among the most stable businesses around.
With the Nasdaq Composite still firmly entrenched in bear market territory, if you're feeling discouraged about the state of your portfolio and the performance of some of your favorite stocks, you're certainly not alone. Two stocks that in my view belong firmly in the former category are DexCom (NASDAQ: DXCM) and Procter & Gamble (NYSE: PG). If you're searching for a non-cyclical company with products that are consistently in demand, regardless of the macro environment or consumer sentiment, DexCom could be a no-brainer contender for your portfolio.